FOLH1 and prostate carcinoma: Table 1 summarizes reported sensitivities across PSA ranges, demonstrating increased detection at higher PSA values. Specificity is consistently high across all PSA values, exceeding 90%, as PSMA expression is highly specific for prostate cancer cells [51].